Hem › Lungcancer › Vermont › Burlington
Kliniska studier för Lungcancer i Burlington, VT
4 studier för Lungcancer söker deltagare vid platser i och runt Burlington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekryterarFas 3
- The University of Vermont Medical Center Inc., Burlington
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RekryterarFas 3
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekryterarFas 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Accelerated Pulmonary Rehabilitation in the Preoperative Period
Rekryterar
- University of Vermont Medical Center, Burlington
Lungcancer-studier i andra städer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Arlington, VA41 studier
- Washington, DC41 studier
- Chicago, IL41 studier
- Baltimore, MD40 studier
- Nashville, TN40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
Andra studier i Burlington
- Hjärtsvikt8 studier
- Akut myeloid leukemi7 studier
- Cancer (alla typer)6 studier
- KOL5 studier
- Bröstcancer5 studier
- Leukemi4 studier
- Parkinsons sjukdom4 studier
- Hjärt-kärlsjukdom4 studier
- Cystisk fibros4 studier
- Icke-småcellig lungcancer4 studier
- Prostatacancer4 studier
- Metastaserande cancer4 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.